Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News Researchers discover new target recognised by T cells involved in gut immunosurveillance Researchers in the University of Birmingham’s Institute of Immunology and Immunotherapy have discovered a new target recognised by local T-cells involved in immunosurveillance in the gut.
News Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation
Posted 23 March 2020 The development of more accurate antibody tests for SARS-CoV-2 is crucial and urgent Work to develop tests to detect COVID-19 antibodies is urgent and critically important. Research at universities will be crucial in finding a solution to the current crisis, a University of Birmingham expert has said.
Posted 12 March 2020 Five-year MRC programme grant awarded to University researchers Professor Graham Anderson and his team have been successful in renewing their MRC programme grant 'Targeting New Mechanisms In The Control Of Thymus Function To Restore Balanced T-cell Production'.
Posted 20 February 2020 Birmingham named one of just six new Life Sciences Opportunity Zones The Birmingham Health Partners ecosystem has been awarded Life Sciences Opportunity Zone status by the Department for Business, Energy and Industrial Strategy.
Posted 13 February 2020 Scientists uncover new understanding of how antibodies target dangerous bacteria A new study from the University of Birmingham has helped provide novel understanding into how to select antigens to target in vaccines or new treatments against bacterial infections.
Posted 04 February 2020 Birmingham researcher awarded £1.4 million CRUK Advanced Clinician Scientist Fellowship Dr Shishir Shetty has been awarded a £1.4 million Advanced Clinician Scientist Fellowship from Cancer Research UK to further his research into liver cancer.
Posted 19 November 2019 BSI Tumour Immunology Group Professor Ben Willcox from the University of Birmingham's Institute of Immunology and Immunotherapy writes for the British Society of Immunology on the UK-wide Tumour Immunology Group.